LMS External Advisory Board

The External Advisory Board (EAB) for the Leiomyosarcoma SPORE is chaired by David Tuveson, M.D., Ph.D., Cancer Center Director, and Roy J. Zuckerberg Professor of Cancer Research at Cold Spring Harbor Laboratory

Scientific expertise of the members of the EAB is broad, deep and includes cancer biology, drug development, biostatistical methodology, cancer genetics, patient advocacy, immunology, medical and gynecological oncology, molecular and cellular biology as well as Cancer Center and SPORE leadership. EAB input and advice has already been invaluable in planning and development of this SPORE application, and we look forward to their continued input and evaluation.

Membership	Institution	Expertise
David Tuveson, M.D., Ph.D. EAB Chair	Cold Spring Harbor Laboratory and Cancer Center	Cancer Biology, Modeling, Drug Development, Pancreatic Cancer
Alan Ashworth, Ph.D., FRS	University of California, San Francisco; Helen Diller Comprehensive Cancer Center	Cancer Genetics, Translational Biology
Martee Hensley, M.D.	Memorial Sloan Kettering	Medical Oncology, GYN Oncology, Clinical Trials Research
Robert Maki, M.D., Ph.D.	Memorial Sloan Kettering	Sarcoma Oncology, Clinical Trial Research, Drug Development
Jeffrey S. Morris, Ph.D.	University of Pennsylvania	Biostatistical Methodology, Cancer Research
Raphael Pollock, M.D., Ph.D.	The Ohio State University	Surgical Oncology, Research Scientist
Karlyne Reilly, Ph.D.	National Cancer Institute, Center for Cancer Research, Pediatric Branch	Rare tumors, Molecular and Cellular Biology, Neurofibromatosis
George Weiner, M.D.	University of Iowa	Immunotherapy, Lymphoma, SPORE (PI Lymphoma SPORE)